RU2014124846A - METHOD OF TREATING COSOGLASION IN CHILDREN - Google Patents

METHOD OF TREATING COSOGLASION IN CHILDREN Download PDF

Info

Publication number
RU2014124846A
RU2014124846A RU2014124846A RU2014124846A RU2014124846A RU 2014124846 A RU2014124846 A RU 2014124846A RU 2014124846 A RU2014124846 A RU 2014124846A RU 2014124846 A RU2014124846 A RU 2014124846A RU 2014124846 A RU2014124846 A RU 2014124846A
Authority
RU
Russia
Prior art keywords
day
minutes
exposure
treatment
color
Prior art date
Application number
RU2014124846A
Other languages
Russian (ru)
Inventor
Юсеф Али Альфара
Евгений Иванович Сидоренко
Нателла Вахтанговна Суханова
Original Assignee
Юсеф Али Альфара
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юсеф Али Альфара filed Critical Юсеф Али Альфара
Priority to RU2014124846A priority Critical patent/RU2014124846A/en
Publication of RU2014124846A publication Critical patent/RU2014124846A/en

Links

Abstract

Способ лечения косоглазия у детей с помощью аппарата для инфрацветотерапии АМВО-1, включающий воздействие на глаза инфразвукового пневмомассажа с мощностью от 165 до 170 Дб, частотой от 2 до 5 Гц, в вакууме от 0,05 до 0,10 атм, при экспозиции от 5-15 минут и цветостимуляции с частотой от 2,5 до 4,0 Гц, при экспозиции от 3 до 7 минут, при этом за 2 недели до начала лечения ребенку проводят медикаментозную терапию препаратами: танакан - 10 мг два раза в день, рибоксин - 50 мг три раза в день, капиллар - 125 мг, окулист - 250 мг один раз в день, сана-сол - 10 мл два раза день, за 20 -30 минут до сеанса лечения ребенку назначают 125 мг аспирина и глазные капли: ирифрин 2,5% или тропикамид 0,5%, а непосредственно перед процедурой цветостимуляции закапывают глазные капли - тауфон 4%., курс аппаратного лечения составляет 10 процедур.A method for treating strabismus in children using the AMBO-1 apparatus for infra-color therapy, including exposure to the eyes of an infrasound pneumomassage with a power of 165 to 170 dB, a frequency of 2 to 5 Hz, in a vacuum of 0.05 to 0.10 atm, with an exposure of 5-15 minutes and color stimulation with a frequency of 2.5 to 4.0 Hz, with an exposure of 3 to 7 minutes, while 2 weeks before the start of treatment, the child is given drug therapy with drugs: tanakan - 10 mg twice a day, riboxin - 50 mg three times a day, capillary - 125 mg, optometrist - 250 mg once a day, sana-sol - 10 ml twice a day, per 20-30 minutes before the treatment session, the child is prescribed 125 mg of aspirin and eye drops: irifrin 2.5% or tropicamide 0.5%, and immediately before the procedure of color stimulation, eye drops are added - taufon 4%., The course of hardware treatment is 10 procedures.

Claims (1)

Способ лечения косоглазия у детей с помощью аппарата для инфрацветотерапии АМВО-1, включающий воздействие на глаза инфразвукового пневмомассажа с мощностью от 165 до 170 Дб, частотой от 2 до 5 Гц, в вакууме от 0,05 до 0,10 атм, при экспозиции от 5-15 минут и цветостимуляции с частотой от 2,5 до 4,0 Гц, при экспозиции от 3 до 7 минут, при этом за 2 недели до начала лечения ребенку проводят медикаментозную терапию препаратами: танакан - 10 мг два раза в день, рибоксин - 50 мг три раза в день, капиллар - 125 мг, окулист - 250 мг один раз в день, сана-сол - 10 мл два раза день, за 20 -30 минут до сеанса лечения ребенку назначают 125 мг аспирина и глазные капли: ирифрин 2,5% или тропикамид 0,5%, а непосредственно перед процедурой цветостимуляции закапывают глазные капли - тауфон 4%., курс аппаратного лечения составляет 10 процедур. A method for treating strabismus in children using the AMBO-1 apparatus for infra-color therapy, including exposure to the eyes of an infrasound pneumomassage with a power of 165 to 170 dB, a frequency of 2 to 5 Hz, in a vacuum of 0.05 to 0.10 atm, with an exposure of 5-15 minutes and color stimulation with a frequency of 2.5 to 4.0 Hz, with an exposure of 3 to 7 minutes, while 2 weeks before the start of treatment, the child is given drug therapy with drugs: tanakan - 10 mg twice a day, riboxin - 50 mg three times a day, capillary - 125 mg, optometrist - 250 mg once a day, sana-sol - 10 ml twice a day, per 20-30 minutes before the treatment session, the child is prescribed 125 mg of aspirin and eye drops: irifrin 2.5% or tropicamide 0.5%, and immediately before the procedure of color stimulation, eye drops are added - taufon 4%., The course of hardware treatment is 10 procedures.
RU2014124846A 2014-06-18 2014-06-18 METHOD OF TREATING COSOGLASION IN CHILDREN RU2014124846A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2014124846A RU2014124846A (en) 2014-06-18 2014-06-18 METHOD OF TREATING COSOGLASION IN CHILDREN

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2014124846A RU2014124846A (en) 2014-06-18 2014-06-18 METHOD OF TREATING COSOGLASION IN CHILDREN

Publications (1)

Publication Number Publication Date
RU2014124846A true RU2014124846A (en) 2016-01-27

Family

ID=55237064

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2014124846A RU2014124846A (en) 2014-06-18 2014-06-18 METHOD OF TREATING COSOGLASION IN CHILDREN

Country Status (1)

Country Link
RU (1) RU2014124846A (en)

Similar Documents

Publication Publication Date Title
MX2017005204A (en) Stimulation devices and methods for treating dry eye.
PH12019500892A1 (en) Treating gastric cancer using combination therapies comprising liposomal irinotecan, oxaliplatin, 5-fluoruracil (and leucovorin)
WO2011094758A3 (en) Methods and devices for crosslinking of corneal collagen and for treatment of disorders of the eye
MX2020005547A (en) Modulators of complement activity.
MX2019009190A (en) Use of gaboxadol in the treatment of tinnitus.
MX2017013852A (en) Scalable production of standardized extracellular vesicles, extracellular vesicle preparations and uses thereof.
PH12018502422A1 (en) Nanoliposomal irinotecan for use in treating small cell lung cancer
JOP20200031A1 (en) Methods of treatment of osteoarthritis with transdermal cannabidiol gel
RU2010138239A (en) METHOD FOR TREATING DISEASES OF THE VISUAL NERVE AND RETAIL
RU2014124846A (en) METHOD OF TREATING COSOGLASION IN CHILDREN
MX2019010651A (en) Apparatus and methods for administration of a nauseogenic compound from a drug delivery device.
AR110947A1 (en) TREATMENT OF RETINA DEGENERATION THROUGH THE USE OF PROGENITING CELLS
ZA202104786B (en) Deutetrabenazine for the treatment of dyskinesia in cerebral palsy
WO2018024374A8 (en) Two-dimensional acoustic cr neuromodulation using frequency and periodicity as control parameters
WO2014003850A3 (en) Methods for treatment of ocular diseases
RU2010116789A (en) METHOD FOR TREATING TRAUMATIC NEUROPATHIES
RU2014132577A (en) METHOD FOR TREATMENT OF CHRONIC ALCOHOLISM
RU2011102742A (en) METHOD FOR TREATING INVOLUTIONAL EYE DISEASES
UA102341U (en) Prokopchuk's method for treating gastroduldenal pathology in patients with cerebrovascular diseases
UA109039U (en) METHOD OF CARRYING OUT SURFACE COMBINED FACIAL LIFTING
RU2014151637A (en) METHOD FOR SURGICAL TREATMENT OF PATIENTS WITH PURULENT COMPLICATIONS IN THE ELECTROCARDIUS STIMULATOR AREA WITH PRESERVATION OF THE ACTIVE STIMULATION SYSTEM
UA96506U (en) METHOD OF TREATMENT OF NEUROPATHIES
UA110876U (en) METHOD OF TREATMENT OF TUMER TUBERCULOSIS AND SEED CELLS
UA127485U (en) METHOD OF TREATMENT OF DISEASES CAUSED BY DIABETES
UA87193U (en) Method for treating drug addiction